4//SEC Filing
Claiborne Cary J 4
Accession 0001213900-25-050017
CIK 0001513525other
Filed
Jun 1, 8:00 PM ET
Accepted
Jun 2, 4:01 PM ET
Size
5.6 KB
Accession
0001213900-25-050017
Insider Transaction Report
Form 4
Claiborne Cary J
DirectorChief Executive Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-05-29+138,000→ 138,000 totalExercise: $0.69Exp: 2035-05-28→ Common Stock (138,000 underlying)
Footnotes (1)
- [F1]The option vests pro rata on a monthly basis over 36 months commencing May 29, 2025.
Documents
Issuer
ADIAL PHARMACEUTICALS, INC.
CIK 0001513525
Entity typeother
Related Parties
1- filerCIK 0001370930
Filing Metadata
- Form type
- 4
- Filed
- Jun 1, 8:00 PM ET
- Accepted
- Jun 2, 4:01 PM ET
- Size
- 5.6 KB